Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Pneumococcal infections are a major cause of morbidity and mortality in young children and immaturity of the immune system partly underlies poor vaccine responses seen in the young. Emerging evidence suggests a key role for epigenetics in the maturation and regulation of the immune system in health and disease. The study aimed to investigate epigenetic changes in early life and to understand the relationship between the epigenome and antigen-specific antibody responses to pneumococcal vaccination. METHODS: The epigenetic profiles from 24 healthy children were analyzed at 12 months prior to a booster dose of the 13-valent pneumococcal conjugate vaccine (PCV-13), and at 24 months of age, using the Illumina Methylation 450 K assay and assessed for differences over time and between high and low vaccine responders. RESULTS: Our analysis revealed 721 significantly differentially methylated positions between 12 and 24 months (FDR 

Original publication

DOI

10.1186/s13148-021-01012-w

Type

Journal article

Journal

Clin epigenetics

Publication Date

04/02/2021

Volume

13

Keywords

Childhood, DNA methylation, Epigenetics, Immune system, Pneumococcal vaccination, Vaccine response, Antigen-Antibody Reactions, Case-Control Studies, Cell Competition, Child, Preschool, CpG Islands, DNA Methylation, Epigenesis, Genetic, Female, HLA-DP beta-Chains, Humans, Immune System, Infant, Interleukin-6, Male, Pneumococcal Infections, Pneumococcal Vaccines, Tumor Necrosis Factor Receptor Superfamily, Member 7